dm+d

108777007

Medicine Compliance Aid Stability

FemaraNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Femara
Tablets f/c 2.5mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Store in airtight container and protect from moisture.
17 October 2015

Lactation Safety Information

No
May interfere with lactation
No published evidence of safety
Theoretical risk of impaired development of infant
3 August 2020